Accelerated rTMS: Complexities and clinical translation

Résumé fourni par la source

Major depressive disorder (MDD) is a severe and commonly occurring psychiatric illness with a substantial proportion of patients failing to respond adequately to standard treatments, often referred to as treatment-resistant depression (TRD). Repetitive transcranial magnetic stimulation (rTMS) has been developed as a safe and clinically effective intervention for TRD and is now increasingly accessible in routine clinical settings [1]. Although rTMS produces meaningful antidepressant effects for many patients, the standard delivery schedule is time intensive and clinical response typically occurs gradually.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.